| Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.12M | 4.94M | 4.59M | 3.63M | 5.56M | 4.10M |
| Gross Profit | 738.99K | 1.47M | 1.38M | 1.57M | 2.52M | -1.01M |
| EBITDA | -4.93M | -3.69M | -4.95M | -7.05M | -6.55M | -6.36M |
| Net Income | -3.81M | -3.93M | -5.99M | -5.56M | -4.94M | -3.53M |
Balance Sheet | ||||||
| Total Assets | 9.04M | 11.05M | 10.37M | 13.06M | 12.16M | 11.40M |
| Cash, Cash Equivalents and Short-Term Investments | 2.92M | 3.96M | 1.92M | 2.64M | 1.61M | 182.60K |
| Total Debt | 1.60M | 1.74M | 2.78M | 3.26M | 2.41M | 3.98M |
| Total Liabilities | 3.74M | 4.36M | 5.76M | 6.53M | 5.32M | 6.44M |
| Stockholders Equity | 5.30M | 6.70M | 4.61M | 6.53M | 6.84M | 4.96M |
Cash Flow | ||||||
| Free Cash Flow | -802.53K | -2.54M | -4.06M | -4.45M | -2.76M | -4.56M |
| Operating Cash Flow | -742.87K | -2.35M | -4.04M | -4.33M | -2.57M | -2.85M |
| Investing Cash Flow | -218.45K | -190.60K | -20.38K | -118.17K | -26.90K | -1.71M |
| Financing Cash Flow | -217.78K | 4.80M | 3.37M | 5.51M | 4.08M | 1.81M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £567.11M | 21.88 | 8.49% | 2.09% | 0.49% | 61.73% | |
73 Outperform | £77.79M | 6.13 | 7.39% | ― | 36.61% | ― | |
70 Neutral | £78.95M | 17.26 | 9.34% | ― | 7.36% | 31.93% | |
68 Neutral | £95.02M | 39.32 | 3.88% | 1.56% | 8.75% | -54.73% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £204.77M | -2.93 | -31.42% | ― | -16.33% | -448.12% | |
46 Neutral | £14.20M | -8.18 | -69.49% | ― | 3.38% | 82.76% |
CAP-XX Limited reported unaudited interim results for the half year to 31 December 2025 showing modest top-line growth and improving losses, underpinned by strong demand indicators. Revenue rose 9% year-on-year to A$2.6m, bookings climbed 31% to A$3.4m, billings increased 14%, and order backlog more than doubled to A$2.8m, while the net loss after tax narrowed to A$1.5m and EBITDA loss improved to A$1.1m. The company remains debt-free with A$2.9m in cash and a small net trade debtor position, and has now fully integrated its warehouse management, CRM and accounting systems, yielding better production visibility, cost allocation and financial control. Management frames these operational and systems upgrades, alongside tighter cost discipline, as laying the groundwork for scalable growth, improved margins and a pathway toward cash-flow breakeven, with a strong order book and strengthened distribution and customer relationships expected to support future revenue conversion.
The most recent analyst rating on (GB:CPX) stock is a Sell with a £0.24 price target. To see the full list of analyst forecasts on CAP-XX Ltd stock, see the GB:CPX Stock Forecast page.
CAP-XX Limited has scheduled the release of its interim results for the six months to 31 December 2025 for 2 February 2026, underscoring its commitment to regular financial disclosure as it develops its position in the global supercapacitor market. On the same day, the company’s CEO Lars Stegmann and Interim CFO Anthony Guarna will host a live online presentation for existing and prospective shareholders via the Investor Meet Company platform, signalling an emphasis on investor engagement and transparency around the company’s current trading and strategic progress.
The most recent analyst rating on (GB:CPX) stock is a Sell with a £0.23 price target. To see the full list of analyst forecasts on CAP-XX Ltd stock, see the GB:CPX Stock Forecast page.
CAP-XX Limited has received approval from the Australian Tax Office for an R&D tax credit of A$1.75m, and the funds have been paid to the company, bringing its current cash position to A$2.97m. The tax credit injection strengthens CAP-XX’s near-term liquidity as it continues to develop and commercialise its supercapacitor technology, providing additional financial headroom that may support ongoing R&D activities and underpin operations in a competitive energy storage and power management market.
The most recent analyst rating on (GB:CPX) stock is a Sell with a £0.23 price target. To see the full list of analyst forecasts on CAP-XX Ltd stock, see the GB:CPX Stock Forecast page.
CAP-XX Limited has announced that its total issued ordinary share capital consists of 5,797,326,778 ordinary shares, each with one voting right. This information is crucial for shareholders to determine their interest or changes in interest in the company’s share capital, impacting how they engage with CAP-XX’s financial operations.
The most recent analyst rating on (GB:CPX) stock is a Hold with a £0.50 price target. To see the full list of analyst forecasts on CAP-XX Ltd stock, see the GB:CPX Stock Forecast page.
CAP-XX Ltd has issued 7,303,025 ordinary shares to its Chairman, Dr. Graham Cooley, in lieu of certain fees, as part of its strategy to conserve cash resources. This issuance, priced at 0.275 pence per share, increases Dr. Cooley’s shareholding to 10.53% of the company’s enlarged share capital. The new shares are expected to be admitted to trading on AIM around 20 November 2025, which will adjust the company’s total issued share capital to 5,797,326,778 ordinary shares.
The most recent analyst rating on (GB:CPX) stock is a Hold with a £0.50 price target. To see the full list of analyst forecasts on CAP-XX Ltd stock, see the GB:CPX Stock Forecast page.
CAP-XX Limited announced that Dr. Graham Cooley, the Non-Executive Chairman, has purchased 24,000,000 ordinary shares, increasing his stake to approximately 10.41% of the company’s issued share capital. This move signifies confidence in the company’s future prospects and may influence investor sentiment positively, potentially impacting CAP-XX’s market position and stakeholder interests.
The most recent analyst rating on (GB:CPX) stock is a Hold with a £0.50 price target. To see the full list of analyst forecasts on CAP-XX Ltd stock, see the GB:CPX Stock Forecast page.